ACHIEVE-5 tested the oral GLP-1 drug in combination with a basal insulin regimen ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

For decades, type 2 diabetes was viewed as a progressive disease that could be managed but not reversed. Patients were often ...

Dihydropyridine calcium-channel-blockers (DCCBs), used to treat high blood pressure, could speed up the progression of kidney ...

A new study presented at the American Diabetes Association found that Dexcom’s G7 continuous glucose monitor significantly ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Mifepristone reduced HbA1c and weight in patients with ...

Backed by a meta-analysis of over 4,300 patients, once-weekly tirzepatide slashes blood sugar, weight, and cardiovascular risks more effectively than daily insulin, offering a groundbreaking ...

Game-changing new medications called GLP-1 agonists and SGLT2 inhibitors can not only control blood sugar but also help people lose weight by making them feel full faster, so they eat less. Why is ...

A new study examining the role of continuous glucose monitoring (CGM) in the management of adults with type 2 diabetes who are not on insulin found that CGM substantially reduced hyperglycemia, ...

A large proportion of people living with type 2 diabetes treated with basal insulin therapy remain inadequately controlled ...

It appears that people who have long COVID are at greater risk for heart disease. We encourage you to learn more about your eating behavior and changes needed to be more heart healthy. Q I have ...

UVA Health researcher Daniel J. Cox, PhD, has used the GEM program he developed to put his type 2 diabetes into remission for 15 years. The program emphasizes making educated food choices and doing ...